An Open-Label, Randomized, Multi-Center Study to Evaluate the Efficacy and Safety of Induction with Melphalan/HDS Followed by Trifluridine?tipiracil plus Bevacizumab Versus Trifluridine?tipiracil plus Bevacizumab Alone in Patients with Refractory Metastatic Colorectal Cancer with Liver Dominant Disease

Brief Summary

Type:
Colorectal

Study Type:
Treatment

Phase:
II

ClinicalTrials.gov Identifier:
NCT06607458

Study #:
STUDY00161705

Start Date:
Dec 05, 2025

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT06607458

View Complete Trial Details & Eligibility at ClinicalTrials.gov